genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2010
OSI Pharmaceuticals
Cancer
OSI Accepts Astellas’ Increased $4B Cash Takeover Offer
Insights
Mass Spectrometry’s Role in Discovery on the Rise
Cancer
OSI to Pay $20M to Broaden Cancer Partnership with AVEO
News
OSI Plans Consolidation of U.S. Operations to Save $15M Annually
Cancer
Dako Inks Cancer Companion Diagnostic Alliance with OSI
News
Proteros and OSI Broaden Existing Protein Crystallography Collaboration
News
OSI and AVEO Ally to Advance Therapies that Target Mechanisms of EMT in Cancer
Insights
OSI Pharma Needs to Expand Pipeline
News
Transgenomic Inks Analysis Agreement with OSI
News
Lilly In-Licenses OSI’s Diabetes Program for $25M
1
2
Page 1 of 2
Scroll Up
Scroll Up
